Remaining cities meet salary deadline
Latest newsAll of the local governments in the Tri-Counties that missed California Controller John Chiang’s initial deadline to turn in their salary and benefits data complied with the controller’s request within a few days. The cities of Guadalupe and Grover Beach and the county of Santa Barbara were not on the controller’s original list, released Oct. Read More →
Inphi predicts $10-$12 IPO price
Banking & Finance, Technology, Tri-County Public CompaniesInphi Corp., the chip design firm with a big presence in Ventura County, expects the shares of its initial public offering to sell for between $10 and $12. With shares scheduled to hit the market as early as Nov. 10, Inphi would raise $74.8 million if investors buy in the middle of its range. It Read More →
Simi Valley hospital settles Medicare fraud claim
Latest newsSimi Valley Hospital has paid the U.S. government $5.15 million to settle an allegation that the hospital filed false Medicare claims, the Department of Justice announced Nov. 3. With the settlement finalized, a federal judge dismissed the lawsuit, which was filed in October 2001 by a former hospital employee turned whistleblower. The suit alleged that Read More →
Investec sells $10M property
Real EstateInvestec Real Estate Companies announced Oct. 27 that it has sold a 12-acre residential property in Carpinteria to a developer who plans to build 73 homes there next year. The property, which is part of the Lagunitas mixed-use development, sold for $10 million, Investec said. Investec will keep the 13-acre office portion of Lagunitas. The Read More →
Amgen reports earnings drop
Earnings, Technology, Tri-County Public CompaniesThousand Oaks-based Amgen said Oct. 25 that third-quarter earnings fell 14 percent to $1.3 billion as revenue flatlined. Amgen is the world’s biggest biotech company and the largest private employer in the Tri-Counties. It reported adjusted earnings per share of $1.36, a decrease of 9 percent compared to the same quarter last year. Total revenue Read More →
FDA OKs Aranesp for pre-dialysis patients
Latest news, TechnologyAmgen’s anemia treatment Aranesp is safe for kidney patients whose disease doesn’t require dialysis, a federal panel announced Oct. 18 in response to a study that found the drug could increase stroke risk in those patients. Outside advisers to the U.S. Food and Drug Administration said the treatment shouldn’t be withdrawn or limited to a Read More →
